Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

GlaxoSmithKline Pharmaceuticals informs about details of loss of certificate

15 Jul 2019

GlaxoSmithKline Pharmaceuticals has informed about details of loss of certificate / duplicate certificate. 

The above information is a part of company’s filings submitted to BSE.

Related Glaxosmithkline Pharmaceuticals Ltd. Links:

Glaxosmithkline Phar Share Price

1515.50 35.00 (2.36%) Jun 11, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 681.25
Dr. Reddys Lab 5451.20
Lupin 1230.25
Piramal Enterprises 2252.60
Cadila Healthcare 665.00
View more..
Sensex vs Glaxosmithkline Phar
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback